Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 16976 - 17000 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Ciglitazone	Experimental	CITED2	10370	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of CITED2 mRNA	6q24.1	A21647
Ciglitazone	Experimental	COBLL1	22837	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of COBLL1 mRNA	2q24.3	A21647
Ciglitazone	Experimental	COPA	1314	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of COPA mRNA	1q23.2	A21647
Ciglitazone	Experimental	CSTB	1476	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of CSTB mRNA	21q22.3	A21647
Ciglitazone	Experimental	CTSC	1075	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of CTSC mRNA	11q14.2	A21647
Ciglitazone	Experimental	CYB5R3	1727	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of CYB5R3 mRNA	22q13.2	A21647
Ciglitazone	Experimental	CYP1A2	1544	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of CYP1A2 mRNA	15q24.1	A21647
Ciglitazone	Experimental	CYP1A2	1544	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of CYP1A2 mRNA	15q24.1	A21647
Ciglitazone	Experimental	DKK1	22943	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of DKK1 mRNA	10q21.1	A21647
Ciglitazone	Experimental	DLC1	10395	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of DLC1 mRNA	8p22	A21647
Ciglitazone	Experimental	DOK4	55715	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of DOK4 mRNA	16q21	A21647
Ciglitazone	Experimental	DOK4	55715	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of DOK4 mRNA	16q21	A21647
Ciglitazone	Experimental	EFNA1	1942	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of EFNA1 mRNA	1q22	A21647
Ciglitazone	Experimental	ELF5	2001	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ELF5 mRNA	11p13	A21647
Ciglitazone	Experimental	ELF5	2001	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of ELF5 mRNA	11p13	A21647
Ciglitazone	Experimental	EPAS1	2034	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of EPAS1 mRNA	2p21	A21647
Ciglitazone	Experimental	FABP1	2168	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of FABP1 mRNA	2p11.2	A21647
Ciglitazone	Experimental	FABP1	2168	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of FABP1 mRNA	2p11.2	A21647
Ciglitazone	Experimental	FADS1	3992	upregulated	ciglitazone results in increased expression of FADS1 mRNA	11q12.2	A21650
Ciglitazone	Experimental	FAM102A	399665	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of FAM102A mRNA	9q34.11	A21647
Ciglitazone	Experimental	FAM13A	10144	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of FAM13A mRNA	4q22.1	A21647
Ciglitazone	Experimental	FAM13A	10144	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of FAM13A mRNA	4q22.1	A21647
Ciglitazone	Experimental	FLNB	2317	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of FLNB mRNA	3p14.3	A21647
Ciglitazone	Experimental	FOXO1	2308	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of FOXO1 mRNA	13q14.11	A21647
Ciglitazone	Experimental	GALNT2	2590	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of GALNT2 mRNA	1q42.13	A21647

Displaying entries 16976 - 17000 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability